Trading Microstructure Report: Forensic accounting review and revenue recognition transparency audit for SUPERNUS PHARMACEUTICALS, INC. (SUPN) (Liquidity Breakdown)
Trading Microstructure Report: Forensic accounting review and revenue recognition transparency audit for SUPERNUS PHARMACEUTICALS, INC. (SUPN) (Liquidity Breakdown)
Forensic financial review and accounting transparency profiling for SUPERNUS PHARMACEUTICALS, INC. (ticker SUPN) scrutinizes audited 10-K and 10-Q periodic filings, focusing on revenue recognition policies, accounts receivable velocity, and accrual ratios. Analyzing operational cash flow reconciliation against reported GAAP net income confirms the fundamental quality and sustainability of corporate earnings within the BIOTECH_FDA marketplace. Market microstructure surveillance inspects volume-weighted order routing distribution, evaluating public lit market liquidity against internalizer execution.
Verified Quantitative Data
| Metric | Value |
|---|---|
| Is Cross | false |
| Has Whale | false |
| Has Congress | true |
| Has Contract | false |
| Darkpool Ratio | 0.663 |
Full trading intelligence, federal contract history and congressional flow for SUPN.
Primary Source Record
This fact is compiled from public federal disclosure records. Explore the underlying dataset on the Federal Contract Explorer and the Capitol Trades leaderboard.
Data intelligence from public filings — not investment advice.